111 related articles for article (PubMed ID: 6221545)
1. In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).
Katsura M; Miyamoto T; Hamanaka N; Kondo K; Terada T; Ohgaki Y; Kawasaki A; Tsuboshima M
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():351-7. PubMed ID: 6221545
[No Abstract] [Full Text] [Related]
2. A structural analog of thromboxane A2.
Ansell MF; Caton MP; Palfreyman MN; Stuttle KA; Tuffin D; Walker JL
Adv Prostaglandin Thromboxane Res; 1980; 6():485-7. PubMed ID: 7386282
[No Abstract] [Full Text] [Related]
3. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
[No Abstract] [Full Text] [Related]
4. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
Roth DM; Lefer AM; Smith JB; Nicolaou KC
Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
[TBL] [Abstract][Full Text] [Related]
5. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
[No Abstract] [Full Text] [Related]
6. Syntheses of thromboxane A2 analogs: Thia- and dithiathromboxane A2.
Hamanaka N; Ohuchida S; Hayashi M
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():319-22. PubMed ID: 6221543
[No Abstract] [Full Text] [Related]
7. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
[TBL] [Abstract][Full Text] [Related]
8. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
[TBL] [Abstract][Full Text] [Related]
10. Bioassay of thromboxane A2 by contraction of guinea-pig lung parenchymal strip.
Spławiński J; Wojtaszek B; Marcinkiewicz E
Thromb Res; 1981 Jan 1-15; 21(1-2):35-44. PubMed ID: 6112804
[No Abstract] [Full Text] [Related]
11. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
Gorman RR; Maxey KM; Bundy GL
Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
[No Abstract] [Full Text] [Related]
12. Effects of thromboxane antagonist EP 045 on platelet aggregation.
Jones RL; Wilson NH; Armstrong RA; Peesapati V; Smith GM
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():345-50. PubMed ID: 6303074
[No Abstract] [Full Text] [Related]
13. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
Hammarström S
Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
15. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit.
Morrison AR; Nishikawa K; Needleman P
J Pharmacol Exp Ther; 1978 Apr; 205(1):1-8. PubMed ID: 633076
[No Abstract] [Full Text] [Related]
17. Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035).
Chan CC; Nathaniel DJ; Yusko PJ; Hall RA; Ford-Hutchinson AW
J Pharmacol Exp Ther; 1984 Apr; 229(1):276-82. PubMed ID: 6423813
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2: effects on airway and vascular smooth muscle.
Svenssen J; Strandberg K; Tuvemo T; Hamberg M
Prostaglandins; 1977 Sep; 14(3):425-36. PubMed ID: 905570
[TBL] [Abstract][Full Text] [Related]
19. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins.
Mais DE; Dunlap C; Hamanaka N; Halushka PV
Eur J Pharmacol; 1985 Apr; 111(1):125-8. PubMed ID: 4018122
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of stable thromboxane A2 analogs: pinane thromboxane A2 (PTA2) and carbocyclic thromboxane A2 (CTA2).
Nicolaou KC; Magolda RL
Methods Enzymol; 1982; 86():400-9. PubMed ID: 7132765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
